• AnaptysBio Reports Imsidolimab ACORN Phase 2 Clinical Trial Data in Moderate-to-Severe Acne

    Source: Nasdaq GlobeNewswire / 14 Mar 2022 16:20:00   America/New_York

    N/A
Share on,